Herbs & Botanicals

A placebo-controlled study on Ixoreal's standardized root extract points to reductions in hot flashes, stress, and mood symptoms after eight weeks of supplementation.

The physician-founded brand pairs its HPLC-verified polyphenol base with Greek beetroot for a new endurance-focused formula.

Researchers in Malaysia tested light and water combinations on young Tongkat Ali plants, providing data that could inform how the increasingly sought-after botanical is replanted and managed for long-term supply.

A look at the research, safety data, and quality-control challenges shaping the berberine ingredient market for supplement manufacturers.

Clinical trial finds 200 mg of bio-optimized berberine improves blood glucose, GLP-1, and lipid markers at doses lower than conventional berberine.

The root-only ingredient's new verification arrives alongside clinical data on bioavailability, stress, and sleep.

The deal brings in a Paris-based agrifood investor and two additional French partners to back acquisitions and clinical research, while founder Jeff Wuagneux stays at the helm.

A new randomized, placebo-controlled trial examined the combined botanical's effects, finding support for hot flashes, sleep, mood, and hormone levels.

The deal, expected to be finalized by the end of the year, would combine botanical extraction, fermented nutrients, and natural color and flavor operations under one supplier, reshaping sourcing options for finished product manufacturers across nutraceuticals and food enhancement.

The agreement between the trade association and India's SHEFEXIL formalizes a relationship aimed at improving traceability and scientific collaboration for botanical ingredients flowing between the two countries' supplement industries.

The updated site reorganizes clinical and mechanistic data on the company's Andrographis paniculata extract, reflecting a broader industry trend toward more transparent, formulator-facing ingredient education.

SRI-81 Shatavari, produced by Ixoreal Biomed, and distributed in Canada by CK Nutraceuticals has earned a Natural Product Number from Health Canada, allowing brands that use the ingredient to utilize 5 approved health claims that include peri- and menopause support as well as sexual health claims.

The scheduling does not apply to botanical kratom, but rather synthetically derived 7-hydroxymitragynine (7-OH), MP, MGM-15, and MGM-16, which the plant contains in small amounts.

Alkemist Labs names Mo Lababidi to lead botanical identity testing amid continued focus on supplement quality compliance.

Tracing ingredients from sourcing through testing supports clean-label claims and customer confidence in finished products.

At The Outlook on Women’s Wellness, Jennifer Greer, ND, Med, explained how functional botanicals address sleep, mood, and metabolism for menopausal transition phases.

BAPP releases new Laboratory Guidance Document to help supplement manufacturers optimize testing protocols and ensure cGMP compliance.

The randomized, double-blind, placebo-controlled crossover study showed short-term supplementation with the extract delivers dose-dependent benefits in both power output and brain focus.

The portfolio includes four mushroom blends targeting the energy, focus, immunity, and relaxation markets.

A 12-week study demonstrated KSM-66 Ashwagandha root extract is well tolerated at 2,000 mg/day, maintaining normal liver, kidney, and thyroid parameters.

A NOW study of 28 lavender oils found 89% failed authenticity tests due to dilution, synthetic additives, and species substitution, linking low cost to poor quality.

Symrise and Probi expanded formulation horizons at Vitafoods Europe, launching stable postbiotics and clinical botanicals for active nutrition and wellness.

The recognition for Ashwa.30 at the Barcelona show highlights a broader industry interest in clinically studied, low-dose botanical ingredients targeting sports nutrition, stress support, and active lifestyle formulations.

With clinical data validating centuries of traditional use, shatavari is emerging as one of the most versatile ingredients in women's health, supporting menopause, hormone balance, lactation, and sexual health.

Ministry of Ayush restricts the use of ashwagandha leaves in extracts citing potential injury. While these restrictions were put into place in India where many ashwagandha products are produced, it's unclear what the impact will be on US ashwagandha inventory. Additionally, brands that use ashwagandha leaves in extracts defend the effectiveness and safety of their products.